STAT4/Epac1信号介导的线粒体代谢功能障碍在睡眠呼吸暂停相关肺血管重构中的作用及机制研究
批准号:
82100109
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
符翠萍
依托单位:
学科分类:
睡眠呼吸障碍与呼吸调控
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
符翠萍
中文摘要
慢性间歇低氧(CIH)是睡眠呼吸暂停综合征(SAS)最主要的病生表现,与持续低氧诱导肺动脉高压(PH)机制不同,CIH诱导PH的具体病理机制尚不明确,CIH可诱导肺血管重构,阻断CIH相关肺血管重构有望特异性干预SAS相关PH的发生发展过程。我们预实验结果发现cAMP蛋白激活的交换蛋白1(Epac1)分子表达在CIH模型下特异性表达升高,下调Epac1基因表达后糖酵解水平下降,信号转导与转录激活因子4(STAT4)与Epac1启动子结合并调控Epac1表达,基此提出CIH可通过STAT4/Epac1介导线粒体代谢功能障碍,进而促进糖酵解,导致肺血管重构的发生。本项目拟利用Epac1基因敲除小鼠,构建CIH模型,结合基因干扰和免疫共沉淀等技术,研究CIH条件下STAT4/Epac1信号调控线粒体代谢及其在在肺血管重构中的作用和机制,为临床特异性防治SAS相关PH提供治疗靶点和理论基础。
英文摘要
Chronic intermittent hypoxia (CIH) is the most important pathophysiology of sleep apnea syndrome (SAS). The mechanism of CIH associated with pulmonary hypertension (PH), which is different from sustained hypoxia associated PH, is unknown yet. Studies have shown that CIH could lead to pulmonary vascular remodeling, and blocking CIH-related pulmonary vascular remodeling is expected to specially block the occurrence and development of SAS related PH. Our further preliminary experiments found that CIH increased the expression of cyclic adenosine monophosphate (cAMP)-activated exchange protein 1 (Epac1) and promoted glycolysis metabolism, however, the glycolysis level decreased after the knockdown of Epac1, signal transducer and activator of transcription 4 (STAT4) combined with the promoter region of Epac1 and regulated the expression of Epac1. These results suggest that CIH leads to pulmonary vascular remodeling through STAT4/Epac1 mediated mitochondrial metabolic dysfunction. We intends to use Epac1 gene knockout mice, build CIH model in vivo and in vitro, apply metabolic regulators, co-immunoprecipitation and gene interference technologies in this project, in order to study the role of STAT4/Epac1 signal in pulmonary vascular remodeling under the condition of CIH, and to explore the related mechanism about mitochondrial metabolism. This project is aimed to provide a possible therapeutic target and theoretical basis for the accurate prevention and treatment of SAS related PH.
睡眠呼吸暂停低通气综合征可诱发包括肺动脉高压在内的一系列严重心血管疾病,但其发病机制尚不明确。本研究建立间歇低氧(CIH)体内外模型,发现CIH后小鼠右心室收缩压明显增加,同时肺小动脉血管壁增厚,在体内实验中证实了CIH能够引起肺血管重构、诱导PH发生;在体外实验中,证实了CIH能促进人类肺动脉平滑肌细胞(HPASMCs)过度增殖及迁移。小鼠肺组织IHC结果提示Epac1在CIH组小鼠肺组织中表达较对照组升高。EPAC1抑制剂(CE3F4)能够抑制CIH条件下HPASMCs的过度增殖及迁移。本研究发现,相较于对照组,CIH组HPASMCs的葡萄糖消耗量和乳酸生成量明显增加,细胞氧气消耗速率显著降低,且细胞外酸化速率显著升高。Epac1抑制剂CE3F4使CIH组HPASMCs的葡萄糖消耗率降低,乳酸生成量减少,改善OCR及ECAR;CIH组细胞内ATP总量明显降低,以糖酵解生成ATP为主,抑制Epac1可降低糖酵解生成ATP,这提示CIH可能通过激活Epac1信号诱导HPASMCs发生糖酵解转换;Epac1受抑制后可降低CIH组HPASMCs胞质内钙离子浓度,CIH作用下HPASMCs细胞内线粒体膜电位降低,抑制Epac1后线粒体膜电位升高,Epac1通过调控HPASMCs钙离子稳态进而导致线粒体发生糖酵解诱导CIH并发肺动脉高压;本研究证明CIH可能通过激活Epac1信号导致线粒体功能障碍,诱导HPASMCs发生能量代谢重编程,进而促进肺血管重构,最终导致肺动脉高压。揭示了Epac1对CIH 作用下肺血管重构及肺动脉平滑肌细胞代谢功能变化的调控作用及机制,为OSA相关肺动脉高压治疗提供新思路及新靶点。
国内基金
海外基金